Daxor (DXR) vs Utah Medical Products (UTMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Utah Medical Products (UTMD) has outperformed Daxor (DXR) over the past year, gaining 16.5% versus a loss of 20.0%. Over five years, DXR leads with a -7.0% price change compared with -17.9% for UTMD. Utah Medical Products is the larger company by market cap ($234.3 million vs $61.2 million), about 3.8 times the size.
On valuation, Daxor trades at a lower trailing P/E (9.5x vs 22.5x for Utah Medical Products). Utah Medical Products pays a dividend yielding 1.67%, while Daxor does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DXR | UTMD |
|---|---|---|
| Share price | $10.49 | $73.81 |
| Market cap | $61.21M | $234.26M |
| 1-day change | +0.24% | -0.09% |
| YTD return | -29.08% | +32.01% |
| 1-year return | -20.03% | +16.47% |
| 5-year return | -7.02% | -17.93% |
| P/E ratio (TTM) | 9.53 | 22.50 |
| EPS (TTM) | $1.10 | $3.28 |
| Dividend yield | 0.00% | 1.67% |
| Annual dividend | $0.00 | $1.24 |
| 52-week high | $14.76 | $76.89 |
| 52-week low | $8.56 | $53.66 |
| Distance from 52-week high | -28.96% | -4.01% |
| Analyst consensus | none | — |
| Avg. price target upside | +90.75% | — |
| Average volume | 17.27K | 34.56K |
| Shares outstanding | 5.84M | 3.17M |
| Employees | — | 140 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Utah Medical Products is about 3.8 times larger than Daxor by market value ($234.26M vs $61.21M).
- UTMD has outperformed DXR by 36.5 percentage points over the past year.
- Utah Medical Products trades at a higher earnings multiple (22.5x vs 9.5x trailing P/E).
- Utah Medical Products offers a meaningfully higher dividend yield (1.67% vs 0.00%).
About Daxor
DXR stock →Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.
Health Care · Medical/Dental Instruments
About Utah Medical Products
UTMD stock →Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally.
Health Care · Medical/Dental Instruments · 140 employees
DXR vs UTMD FAQ
Which is bigger, Daxor or Utah Medical Products?
Utah Medical Products (UTMD) is larger, with a market capitalization of $234.26M compared with $61.21M for Daxor (DXR).
Which stock has performed better over the past year, DXR or UTMD?
UTMD returned +16.47% over the past 12 months, compared with -20.03% for DXR (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, DXR or UTMD?
DXR has the lower trailing P/E at 9.5, versus 22.5 for UTMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Daxor or Utah Medical Products?
Utah Medical Products pays a dividend yielding 1.67%, while Daxor does not currently pay a regular dividend.
Are Daxor and Utah Medical Products in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.